|
|
| May 7, 2009: Dr. Magnus E. Ohman presents Optimal Upstream Anti-Thrombin Therapy |
Dr. Magnus E. Ohman presents Optimal Upstream Anti-Thrombin Therapy at the 2009 SCAI
Scientific Sessions in Las Vegas.
Research Grants
-Sanofi-Aventis, Schering-Plough, Eli Lilly, Daiichi-Sankyo, Bristol-Myers Squibb, CV
Therapeutics, Datascope, and the Medicines Company
Stock Ownership
-Inovise
Consultant
-Response Biomedical, Northpoint Domain, CV Therapeutics, The Medicines Company, Abiomed,
Datascope, Liposcience and Inovise Medical
[ Download video ] |
|
No comments have been submitted
|